Global Cannabidiol (CBD) Market By Source Type (Hemp, Marijuana), By Distribution Channel (B2B, B2C), By End-use (Medical, Personal Use), By Country, and Manufacture - Industry Segment, Competition Scenario and Forecast by 2029
Categories: Consumer Goods
Formate : 
Global Cannabidiol (CBD) Market was valued at USD XX Billion in the year 2020. Global Cannabidiol (CBD) Market is further estimated to grow at a CAGR of XX% from 2021 to 2030 it will reach USD XX Billion by the year 2030. The North America region holds the highest market share in 2020 and the Asia Pacific is considered as the fastest growing market in the forecasted period. At a country level, US, China are projected to grow strongly in the coming years due to increasing density of population and funding through Research and Development.
The Global Cannabidiol (CBD) Report 2021-2030 covers market opportunities and challenges, key market regulations’ information, analysis of new products from the market players and key market trends, market share analysis for key players, supply chain and value chain analysis, product and Material trends, pricing analysis, emerging applications, technologies and major recent developments. This information has also been provided for the major country markets in these regions. Market shares, size and growth potential are assessed for these major country markets. Market opportunities, challenges, government regulations, market share analysis by major competitors, recent major market developments (product launches, M&A, partnerships, etc.) and other information have been covered for the major country markets listed in this section.
On the basis of Type, the market is divided as Oil, Tinctures, Suppository, Transdermal Patches, Isolates, Tablet, Capsules, Vape Oil, Creams And Roll-On. In which Oil for the largest market share due to increasing demand in future market trends. Regional breakdown and deep analysis of each of the aforesaid segments is included for North America, Europe, Asia-Pacific, and ROW.
Market player analysis of major companies such as ENDOCA; Cannoid, LLC; Medical Marijuana, Inc.; Folium Biosciences; Elixinol; NuLeaf Naturals, LLC; Isodiol International, Inc.; Pharmahemp d.o.o..
![]()
The Global Cannabidiol (CBD) Report 2021-2030 covers market opportunities and challenges, key market regulations’ information, analysis of new products from the market players and key market trends, market share analysis for key players, supply chain and value chain analysis, product and Material trends, pricing analysis, emerging applications, technologies and major recent developments. This information has also been provided for the major country markets in these regions. Market shares, size and growth potential are assessed for these major country markets. Market opportunities, challenges, government regulations, market share analysis by major competitors, recent major market developments (product launches, M&A, partnerships, etc.) and other information have been covered for the major country markets listed in this section.
On the basis of Type, the market is divided as Oil, Tinctures, Suppository, Transdermal Patches, Isolates, Tablet, Capsules, Vape Oil, Creams And Roll-On. In which Oil for the largest market share due to increasing demand in future market trends. Regional breakdown and deep analysis of each of the aforesaid segments is included for North America, Europe, Asia-Pacific, and ROW.
Market player analysis of major companies such as ENDOCA; Cannoid, LLC; Medical Marijuana, Inc.; Folium Biosciences; Elixinol; NuLeaf Naturals, LLC; Isodiol International, Inc.; Pharmahemp d.o.o..
| Particular | Scope |
|---|---|
| Region |
|
| Historic Year | 2016-2020 |
| Base Year | 2021 |
| Forecast Year | 2022 - 2030 |
| Quantitative units | Revenue in USD million/billion and CAGR from 2022 to 2030 |
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered | Component, technology, type, application, region |
This research report will answer the following questions:
- Which are the major players and what are their business plans on a global scale?
- Which are the major industry regions?
- Growth opportunities and trend analysis?
- Competition strategy and market share analysis?
1 INTRODUCTION
1.1 OBJECTIVES
1.2 RESEARCH METHODOLOGY
1.2.1 SECONDARY DATA
1.2.2 PRIMARY DATA
1.2.3 MARKET SIZE ESTIMATION
1.2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
1.3 STAKEHOLDERS
1.4 RESEARCH ASSUMPTIONS
1.5 LIMITATION
2 EXECUTIVE SUMMARY
3 MARKET OUTLOOK
3.1 INTRODUCTION
3.2 OPPORTUNITIES MATRIX
3.3 MARKET CHALLENGES
3.4 MARKET SHARE ANALYSIS
3.5 VALUE CHAIN ANALYSIS
3.6 DEMAND SIDE ANALYSIS
3.7 SUPPLY SIDE ANALYSIS
3.8 PORTER’S FIVE FORCES MODEL
3.8.1 DEGREE OF COMPETITION
3.8.2 BARGAINING POWER OF BUYERS
3.8.3 BARGAINING POWER OF SUPPLIERS
3.8.4 THREAT FROM SUBSTITUTES
3.8.5 THREAT FROM NEW ENTRANTS
4 INDUSTRY TRENDS
4.1 PRODUCT LIFE CYCLE
4.2 NEW MARKET ENTRY STRATEGY
4.3 PESTEL ANALYSIS
4.4 PRICING ANALYSIS
4.5 TRADE DATA
4.6 TECHNOLOGICAL OVERVIEW
4.7 FUTURE OUTLOOK MARKET TRENDS
4.8 MACRO-ECONOMIC VARIABLES (DEPENDENT AND INDEPENDENT VARIABLES)
4.9 MULTIFACTOR BASED SENSITIVITY ANALYSIS
4.10 REGRESSION MATRIX
4.11 COVID-19 IMPACT ANALYSES
4.12 GE MATRIX
5 CANNABIDIOL (CBD) TYPE ANALYSIS
5.1 INTRODUCTION
5.2 HISTORICAL MARKET TYPE ANALYSIS, 2015-2019
5.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030
5.4 Y-O-Y GROWTH TREND ANALYSIS
5.5 OIL
5.6 TINCTURES
5.7 SUPPOSITORY
5.8 TRANSDERMAL PATCHES
5.9 ISOLATES
5.10 TABLET
5.11 CAPSULES
5.12 VAPE OIL
5.13 CREAMS AND ROLL-ON
5.14 OTHERS
6 CANNABIDIOL (CBD) ROUTE OF ADMINISTRATION ANALYSIS
6.1 INTRODUCTION
6.2 HISTORICAL MARKET ROUTE OF ADMINISTRATION ANALYSIS, 2015-2019
6.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030
6.4 Y-O-Y GROWTH TREND ANALYSIS
6.5 ORAL
6.6 TOPICAL
6.7 INHALATION
6.8 TRANSDERMAL PATCHES
6.9 RECTAL
6.10 SUBLINGUAL
7 CANNABIDIOL (CBD) SOURCE TYPE ANALYSIS
7.1 INTRODUCTION
7.2 HISTORICAL MARKET SOURCE TYPE ANALYSIS, 2015-2019
7.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030
7.4 Y-O-Y GROWTH TREND ANALYSIS
7.5 HEMP
7.6 MARIJUANA
8 CANNABIDIOL (CBD) DISTRIBUTION CHANNEL ANALYSIS
8.1 INTRODUCTION
8.2 HISTORICAL MARKET DISTRIBUTION CHANNEL ANALYSIS, 2015-2019
8.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030
8.4 Y-O-Y GROWTH TREND ANALYSIS
8.5 B2B
8.6 B2C
8.6.1 HOSPITAL PHARMACIES
8.6.2 ONLINE
8.6.3 RETAIL STORES
9 CANNABIDIOL (CBD) END-USE ANALYSIS
9.1 INTRODUCTION
9.2 HISTORICAL MARKET END-USE ANALYSIS, 2015-2019
9.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030
9.4 Y-O-Y GROWTH TREND ANALYSIS
9.5 MEDICAL
9.5.1 CHRONIC PAIN
9.5.2 MENTAL DISORDERS
9.5.3 CANCER
9.5.4 OTHERS
9.6 PERSONAL USE
9.7 PHARMACEUTICALS
9.8 WELLNESS
9.8.1 FOOD & BEVERAGES
9.8.2 PERSONAL CARE & COSMETICS
9.8.3 NUTRACEUTICALS
9.8.4 OTHERS
10 CANNABIDIOL (CBD) MARKET APPLICATION ANALYSIS
10.1 INTRODUCTION
10.2 HISTORICAL MARKET APPLICATION ANALYSIS, 2015-2019
10.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030
10.4 Y-O-Y GROWTH TREND ANALYSIS
10.5 ANXIETY/STRESS
10.6 SLEEP/INSOMNIA
10.7 CHRONIC PAIN
10.8 MIGRAINES
10.9 SKIN CARE
10.10 SEIZURES
10.11 JOINT PAIN & INFLAMMATION
10.12 NEUROLOGICAL CONDITIONS
10.13 OTHERS
11 GLOBAL CANNABIDIOL (CBD) REGIONAL ANALYSIS
11.1 INTRODUCTION
11.2 NORTH AMERICA
11.2.1 NORTH AMERICA HISTORICAL MARKET COUNTRY ANALYSIS, 2015-2019
11.2.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030
11.2.3 Y-O-Y GROWTH TREND ANALYSIS
11.2.3.1 U.S.
11.2.3.2 Canada
11.2.3.3 Mexico
11.3 ASIA-PACIFIC
11.3.1 APAC HISTORICAL MARKET COUNTRY ANALYSIS, 2015-2019
11.3.2 Y-O-Y GROWTH TREND ANALYSIS
11.3.2.1 China
11.3.2.2 Japan
11.3.2.3 Korea
11.3.2.4 India
11.3.2.5 Southeast Asia
11.4 MIDDLE EAST AND AFRICA
11.4.1 MIDDLE EAST AND AFRICA HISTORICAL MARKET COUNTRY ANALYSIS, 2015-2019
11.4.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030
11.4.3 Y-O-Y GROWTH TREND ANALYSIS
11.4.3.1 Saudi Arabia
11.4.3.2 UAE
11.4.3.3 Egypt
11.4.3.4 Nigeria
11.4.3.5 South Africa
11.5 EUROPE
11.5.1 EUROPE HISTORICAL MARKET COUNTRY ANALYSIS, 2015-2019
11.5.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030
11.5.3 Y-O-Y GROWTH TREND ANALYSIS
11.5.3.1 Germany
11.5.3.2 France
11.5.3.3 UK
11.5.3.4 Russia
11.5.3.5 Italy
11.6 SOUTH AMERICA
11.6.1 SOUTH AMERICA HISTORICAL MARKET COUNTRY ANALYSIS, 2015-2019
11.6.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030
11.6.3 Y-O-Y GROWTH TREND ANALYSIS
11.6.3.1 Brazil
11.6.3.2 Argentina
11.6.3.3 Columbia
12 MARKET PLAYERS
12.1 ENDOCA
12.1.1 BUSINESS OVERVIEW:
12.1.2 PRODUCT PORTFOLIO
12.1.3 RECENT DEVELOPMENTS
12.1.4 SWOT ANALYSIS:
12.2 CANNOID, LLC
12.3 MEDICAL MARIJUANA, INC.
12.4 FOLIUM BIOSCIENCES
12.5 ELIXINOL
12.6 NULEAF NATURALS, LLC
12.7 ISODIOL INTERNATIONAL, INC.
12.8 PHARMAHEMP D.O.O.
12.9 CANOPY GROWTH CORPORATION
12.10 CV SCIENCES
12.11 AURORA CANNABIS
12.12 MARICANN, INC. (WAYLAND GROUP CORPORATION)
12.13 TILRAY
12.14 GW PHARMACEUTICALS, PLC
12.15 ABCANN MEDICINALS, INC. (VIVO CANNABIS)
12.16 ORGANIGRAM HOLDING, INC.
12.17 TIKUN OLAM
12.18 THE CRONOS GROUP
12.19 KAZMIRA
12.20 IRIECBD
12.21 CURA CANNABIS SOLUTIONS
12.22 CBD AMERICAN SHAMAN
12.23 GENERAL CANNABIS CORP.
12.24 INSYS THERAPEUTICS, INC
12.25 PHYTO ANIMAL HEALTH
13 ABOUT US
1.1 OBJECTIVES
1.2 RESEARCH METHODOLOGY
1.2.1 SECONDARY DATA
1.2.2 PRIMARY DATA
1.2.3 MARKET SIZE ESTIMATION
1.2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
1.3 STAKEHOLDERS
1.4 RESEARCH ASSUMPTIONS
1.5 LIMITATION
2 EXECUTIVE SUMMARY
3 MARKET OUTLOOK
3.1 INTRODUCTION
3.2 OPPORTUNITIES MATRIX
3.3 MARKET CHALLENGES
3.4 MARKET SHARE ANALYSIS
3.5 VALUE CHAIN ANALYSIS
3.6 DEMAND SIDE ANALYSIS
3.7 SUPPLY SIDE ANALYSIS
3.8 PORTER’S FIVE FORCES MODEL
3.8.1 DEGREE OF COMPETITION
3.8.2 BARGAINING POWER OF BUYERS
3.8.3 BARGAINING POWER OF SUPPLIERS
3.8.4 THREAT FROM SUBSTITUTES
3.8.5 THREAT FROM NEW ENTRANTS
4 INDUSTRY TRENDS
4.1 PRODUCT LIFE CYCLE
4.2 NEW MARKET ENTRY STRATEGY
4.3 PESTEL ANALYSIS
4.4 PRICING ANALYSIS
4.5 TRADE DATA
4.6 TECHNOLOGICAL OVERVIEW
4.7 FUTURE OUTLOOK MARKET TRENDS
4.8 MACRO-ECONOMIC VARIABLES (DEPENDENT AND INDEPENDENT VARIABLES)
4.9 MULTIFACTOR BASED SENSITIVITY ANALYSIS
4.10 REGRESSION MATRIX
4.11 COVID-19 IMPACT ANALYSES
4.12 GE MATRIX
5 CANNABIDIOL (CBD) TYPE ANALYSIS
5.1 INTRODUCTION
5.2 HISTORICAL MARKET TYPE ANALYSIS, 2015-2019
5.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030
5.4 Y-O-Y GROWTH TREND ANALYSIS
5.5 OIL
5.6 TINCTURES
5.7 SUPPOSITORY
5.8 TRANSDERMAL PATCHES
5.9 ISOLATES
5.10 TABLET
5.11 CAPSULES
5.12 VAPE OIL
5.13 CREAMS AND ROLL-ON
5.14 OTHERS
6 CANNABIDIOL (CBD) ROUTE OF ADMINISTRATION ANALYSIS
6.1 INTRODUCTION
6.2 HISTORICAL MARKET ROUTE OF ADMINISTRATION ANALYSIS, 2015-2019
6.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030
6.4 Y-O-Y GROWTH TREND ANALYSIS
6.5 ORAL
6.6 TOPICAL
6.7 INHALATION
6.8 TRANSDERMAL PATCHES
6.9 RECTAL
6.10 SUBLINGUAL
7 CANNABIDIOL (CBD) SOURCE TYPE ANALYSIS
7.1 INTRODUCTION
7.2 HISTORICAL MARKET SOURCE TYPE ANALYSIS, 2015-2019
7.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030
7.4 Y-O-Y GROWTH TREND ANALYSIS
7.5 HEMP
7.6 MARIJUANA
8 CANNABIDIOL (CBD) DISTRIBUTION CHANNEL ANALYSIS
8.1 INTRODUCTION
8.2 HISTORICAL MARKET DISTRIBUTION CHANNEL ANALYSIS, 2015-2019
8.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030
8.4 Y-O-Y GROWTH TREND ANALYSIS
8.5 B2B
8.6 B2C
8.6.1 HOSPITAL PHARMACIES
8.6.2 ONLINE
8.6.3 RETAIL STORES
9 CANNABIDIOL (CBD) END-USE ANALYSIS
9.1 INTRODUCTION
9.2 HISTORICAL MARKET END-USE ANALYSIS, 2015-2019
9.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030
9.4 Y-O-Y GROWTH TREND ANALYSIS
9.5 MEDICAL
9.5.1 CHRONIC PAIN
9.5.2 MENTAL DISORDERS
9.5.3 CANCER
9.5.4 OTHERS
9.6 PERSONAL USE
9.7 PHARMACEUTICALS
9.8 WELLNESS
9.8.1 FOOD & BEVERAGES
9.8.2 PERSONAL CARE & COSMETICS
9.8.3 NUTRACEUTICALS
9.8.4 OTHERS
10 CANNABIDIOL (CBD) MARKET APPLICATION ANALYSIS
10.1 INTRODUCTION
10.2 HISTORICAL MARKET APPLICATION ANALYSIS, 2015-2019
10.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030
10.4 Y-O-Y GROWTH TREND ANALYSIS
10.5 ANXIETY/STRESS
10.6 SLEEP/INSOMNIA
10.7 CHRONIC PAIN
10.8 MIGRAINES
10.9 SKIN CARE
10.10 SEIZURES
10.11 JOINT PAIN & INFLAMMATION
10.12 NEUROLOGICAL CONDITIONS
10.13 OTHERS
11 GLOBAL CANNABIDIOL (CBD) REGIONAL ANALYSIS
11.1 INTRODUCTION
11.2 NORTH AMERICA
11.2.1 NORTH AMERICA HISTORICAL MARKET COUNTRY ANALYSIS, 2015-2019
11.2.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030
11.2.3 Y-O-Y GROWTH TREND ANALYSIS
11.2.3.1 U.S.
11.2.3.2 Canada
11.2.3.3 Mexico
11.3 ASIA-PACIFIC
11.3.1 APAC HISTORICAL MARKET COUNTRY ANALYSIS, 2015-2019
11.3.2 Y-O-Y GROWTH TREND ANALYSIS
11.3.2.1 China
11.3.2.2 Japan
11.3.2.3 Korea
11.3.2.4 India
11.3.2.5 Southeast Asia
11.4 MIDDLE EAST AND AFRICA
11.4.1 MIDDLE EAST AND AFRICA HISTORICAL MARKET COUNTRY ANALYSIS, 2015-2019
11.4.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030
11.4.3 Y-O-Y GROWTH TREND ANALYSIS
11.4.3.1 Saudi Arabia
11.4.3.2 UAE
11.4.3.3 Egypt
11.4.3.4 Nigeria
11.4.3.5 South Africa
11.5 EUROPE
11.5.1 EUROPE HISTORICAL MARKET COUNTRY ANALYSIS, 2015-2019
11.5.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030
11.5.3 Y-O-Y GROWTH TREND ANALYSIS
11.5.3.1 Germany
11.5.3.2 France
11.5.3.3 UK
11.5.3.4 Russia
11.5.3.5 Italy
11.6 SOUTH AMERICA
11.6.1 SOUTH AMERICA HISTORICAL MARKET COUNTRY ANALYSIS, 2015-2019
11.6.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030
11.6.3 Y-O-Y GROWTH TREND ANALYSIS
11.6.3.1 Brazil
11.6.3.2 Argentina
11.6.3.3 Columbia
12 MARKET PLAYERS
12.1 ENDOCA
12.1.1 BUSINESS OVERVIEW:
12.1.2 PRODUCT PORTFOLIO
12.1.3 RECENT DEVELOPMENTS
12.1.4 SWOT ANALYSIS:
12.2 CANNOID, LLC
12.3 MEDICAL MARIJUANA, INC.
12.4 FOLIUM BIOSCIENCES
12.5 ELIXINOL
12.6 NULEAF NATURALS, LLC
12.7 ISODIOL INTERNATIONAL, INC.
12.8 PHARMAHEMP D.O.O.
12.9 CANOPY GROWTH CORPORATION
12.10 CV SCIENCES
12.11 AURORA CANNABIS
12.12 MARICANN, INC. (WAYLAND GROUP CORPORATION)
12.13 TILRAY
12.14 GW PHARMACEUTICALS, PLC
12.15 ABCANN MEDICINALS, INC. (VIVO CANNABIS)
12.16 ORGANIGRAM HOLDING, INC.
12.17 TIKUN OLAM
12.18 THE CRONOS GROUP
12.19 KAZMIRA
12.20 IRIECBD
12.21 CURA CANNABIS SOLUTIONS
12.22 CBD AMERICAN SHAMAN
12.23 GENERAL CANNABIS CORP.
12.24 INSYS THERAPEUTICS, INC
12.25 PHYTO ANIMAL HEALTH
13 ABOUT US
TABLE 1 CANNABIDIOL (CBD) REGIONAL ANALYSIS, 2020–2030 (USD MILLION)
TABLE 2 GLOBAL CANNABIDIOL (CBD) MARKET, 2020–2030, (USD MILLION)
TABLE 3 CANNABIDIOL (CBD) CURRENT AND FUTURE REGIONAL ANALYSIS, 2020–2030 (USD MILLION)
TABLE 4 GLOBAL CANNABIDIOL (CBD) HISTORICAL MARKET TYPE ANALYSIS, 2015-2019, (USD MILLION)
TABLE 5 CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 6 GLOBAL CANNABIDIOL (CBD) HISTORICAL MARKET ROUTE OF ADMINISTRATION ANALYSIS, 2015-2019, (USD MILLION)
TABLE 7 CANNABIDIOL (CBD) CURRENT AND FUTURE ROUTE OF ADMINISTRATION ANALYSIS, 2020–2030 (USD MILLION)
TABLE 8 GLOBAL CANNABIDIOL (CBD) HISTORICAL MARKET SOURCE TYPE ANALYSIS, 2015-2019, (USD MILLION)
TABLE 9 CANNABIDIOL (CBD) CURRENT AND FUTURE SOURCE TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 10 GLOBAL CANNABIDIOL (CBD) HISTORICAL MARKET DISTRIBUTION CHANNEL ANALYSIS, 2015-2019, (USD MILLION)
TABLE 11 CANNABIDIOL (CBD) CURRENT AND FUTURE DISTRIBUTION CHANNEL ANALYSIS, 2020–2030 (USD MILLION)
TABLE 12 GLOBAL CANNABIDIOL (CBD) HISTORICAL MARKET END-USE ANALYSIS, 2015-2019, (USD MILLION)
TABLE 13 CANNABIDIOL (CBD) CURRENT AND FUTURE END-USE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 14 GLOBAL CANNABIDIOL (CBD) HISTORICAL MARKET APPLICATION ANALYSIS, 2015-2019, (USD MILLION)
TABLE 15 CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030 (USD MILLION)
TABLE 16 NORTH AMERICA CANNABIDIOL (CBD) HISTORICAL MARKET ANALYSIS, 2015-2019, (USD MILLION)
TABLE 17 NORTH AMERICA CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 18 NORTH AMERICA CANNABIDIOL (CBD) CURRENT AND FUTURE ROUTE OF ADMINISTRATION ANALYSIS, 2020–2030 (USD MILLION)
TABLE 19 NORTH AMERICA CANNABIDIOL (CBD) CURRENT AND FUTURE SOURCE TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 20 NORTH AMERICA CANNABIDIOL (CBD) CURRENT AND FUTURE DISTRIBUTION CHANNEL ANALYSIS, 2020–2030 (USD MILLION)
TABLE 21 NORTH AMERICA CANNABIDIOL (CBD) CURRENT AND FUTURE END-USE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 22 NORTH AMERICA CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030 (USD MILLION)
TABLE 23 U.S. CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2015–2020
TABLE 24 U.S. CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 25 U.S. CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 26 CANADA CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 27 CANADA CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 28 MEXICO CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 29 MEXICO CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 30 APAC CANNABIDIOL (CBD) HISTORICAL MARKET ANALYSIS, 2015-2019, (USD MILLION)
TABLE 31 ASIA-PACIFIC CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 32 ASIA-PACIFIC CANNABIDIOL (CBD) CURRENT AND FUTURE ROUTE OF ADMINISTRATION ANALYSIS, 2020–2030 (USD MILLION)
TABLE 33 ASIA-PACIFIC CANNABIDIOL (CBD) CURRENT AND FUTURE SOURCE TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 34 ASIA-PACIFIC CANNABIDIOL (CBD) CURRENT AND FUTURE END-USE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 35 ASIA-PACIFIC CANNABIDIOL (CBD) CURRENT AND FUTURE END-USE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 36 ASIA-PACIFIC CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030 (USD MILLION)
TABLE 37 CHINA CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 38 CHINA CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 39 JAPAN CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 40 JAPAN CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 41 KOREA CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 42 KOREA CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 43 INDIA CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 44 INDIA CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 45 SOUTHEAST ASIA CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 46 SOUTHEAST ASIA CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 47 MIDDLE EAST AND AFRICA CANNABIDIOL (CBD) HISTORICAL MARKET ANALYSIS, 2015-2019, (USD MILLION)
TABLE 48 MIDDLE EAST AND AFRICA CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 49 MIDDLE EAST AND AFRICA CANNABIDIOL (CBD) CURRENT AND FUTURE ROUTE OF ADMINISTRATION ANALYSIS, 2020–2030 (USD MILLION)
TABLE 50 MIDDLE EAST AND AFRICA CANNABIDIOL (CBD) CURRENT AND FUTURE DISTRIBUTION CHANNEL ANALYSIS, 2020–2030 (USD MILLION)
TABLE 51 MIDDLE EAST AND AFRICA CANNABIDIOL (CBD) CURRENT AND FUTURE END-USE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 52 MIDDLE EAST AND AFRICA CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030 (USD MILLION)
TABLE 53 SAUDI ARABIA CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 54 SAUDI ARABIA CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 55 UAE CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 56 UAE CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 57 EGYPT CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 58 EGYPT CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 59 NIGERIA CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 60 NIGERIA CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 61 SOUTH AFRICA CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 62 SOUTH AFRICA CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 63 EUROPE CANNABIDIOL (CBD) HISTORICAL MARKET ANALYSIS, 2015-2019, (USD MILLION)
TABLE 64 EUROPE CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 65 EUROPE CANNABIDIOL (CBD) CURRENT AND FUTURE ROUTE OF ADMINISTRATION ANALYSIS, 2020–2030 (USD MILLION)
TABLE 66 EUROPE CANNABIDIOL (CBD) CURRENT AND FUTURE SOURCE TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 67 EUROPE CANNABIDIOL (CBD) CURRENT AND FUTURE DISTRIBUTION CHANNEL ANALYSIS, 2020–2030 (USD MILLION)
TABLE 68 EUROPE CANNABIDIOL (CBD) CURRENT AND FUTURE END-USE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 69 EUROPE CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030 (USD MILLION)
TABLE 70 GERMANY CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 71 GERMANY CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 72 FRANCE CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 73 FRANCE CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 74 UK CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 75 UK CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 76 RUSSIA CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 77 RUSSIA CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 78 ITALY CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 79 ITALY CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 80 SOUTH AMERICA CANNABIDIOL (CBD) HISTORICAL MARKET ANALYSIS, 2015-2019, (USD MILLION)
TABLE 81 SOUTH AMERICA CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 82 SOUTH AMERICA CANNABIDIOL (CBD) CURRENT AND FUTURE ROUTE OF ADMINISTRATION ANALYSIS, 2020–2030 (USD MILLION)
TABLE 83 SOUTH AMERICA CANNABIDIOL (CBD) CURRENT AND FUTURE DISTRIBUTION CHANNEL ANALYSIS, 2020–2030 (USD MILLION)
TABLE 84 SOUTH AMERICA CANNABIDIOL (CBD) CURRENT AND FUTURE END-USE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 85 SOUTH AMERICA CANNABIDIOL (CBD) CURRENT AND FUTURE END-USE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 86 SOUTH AMERICA CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030 (USD MILLION)
TABLE 87 BRAZIL CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 88 BRAZIL CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 89 ARGENTINA CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 90 ARGENTINA CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 91 COLUMBIA CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 92 COLUMBIA CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 1 GLOBAL CANNABIDIOL (CBD) MARKET, 2020–2030, (USD MILLION)
FIGURE 2 RESEARCH METHODOLOGY
FIGURE 3 GLOBAL CANNABIDIOL (CBD) CURRENT AND FUTURE MARKET, 2020–2030, (USD MILLION)
FIGURE 4 GLOBAL CANNABIDIOL (CBD) CURRENT AND FUTURE MARKET, 2020–2030, (USD MILLION)
FIGURE 5 MARKET OVERVIEW
FIGURE 6 SWOT ANALYSIS
FIGURE 7 MARKET SHARE ANALYSIS
FIGURE 8 SUPPLY CHAIN ANALYSIS
FIGURE 9 PORTER’S FIVE FORCES ANALYSIS
FIGURE 10 CANNABIDIOL (CBD) TYPE ANALYSIS
FIGURE 11 GLOBAL CANNABIDIOL (CBD) CURRENT AND FUTURE MARKET TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 12 CANNABIDIOL (CBD) ROUTE OF ADMINISTRATION ANALYSIS
FIGURE 13 GLOBAL CANNABIDIOL (CBD) CURRENT AND FUTURE MARKET ROUTE OF ADMINISTRATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 14 CANNABIDIOL (CBD) SOURCE TYPE ANALYSIS
FIGURE 15 GLOBAL CANNABIDIOL (CBD) CURRENT AND FUTURE MARKET SOURCE TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 16 CANNABIDIOL (CBD) DISTRIBUTION CHANNEL ANALYSIS
FIGURE 17 GLOBAL CANNABIDIOL (CBD) CURRENT AND FUTURE MARKET DISTRIBUTION CHANNEL ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 18 CANNABIDIOL (CBD) END-USE ANALYSIS
FIGURE 19 GLOBAL CANNABIDIOL (CBD) CURRENT AND FUTURE MARKET END-USE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 20 CANNABIDIOL (CBD) APPLICATION ANALYSIS
FIGURE 21 GLOBAL CANNABIDIOL (CBD) CURRENT AND FUTURE MARKET APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 22 GLOBAL CANNABIDIOL (CBD) CURRENT AND FUTURE MARKET VOLUME SHARE REGIONAL ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 23 MARKET OVERVIEW, REGIONAL ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 24 MARKET SHARE BY COUNTRY
FIGURE 25 NORTH AMERICA CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 26 NORTH AMERICA CANNABIDIOL (CBD) CURRENT AND FUTURE ROUTE OF ADMINISTRATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 27 NORTH AMERICA CANNABIDIOL (CBD) CURRENT AND FUTURE SOURCE TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 28 NORTH AMERICA CANNABIDIOL (CBD) CURRENT AND FUTURE DISTRIBUTION CHANNEL ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 29 NORTH AMERICA CANNABIDIOL (CBD) CURRENT AND FUTURE END-USE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 30 NORTH AMERICA CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 31 U.S. CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 32 U.S. CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 33 CANADA CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 34 CANADA CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 35 MEXICO CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 36 MEXICO CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 37 MARKET SHARE BY COUNTRY
FIGURE 38 APAC CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 39 APAC CANNABIDIOL (CBD) CURRENT AND FUTURE ROUTE OF ADMINISTRATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 40 APAC CANNABIDIOL (CBD) CURRENT AND FUTURE SOURCE TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 41 APAC CANNABIDIOL (CBD) CURRENT AND FUTURE END-USE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 42 APAC CANNABIDIOL (CBD) CURRENT AND FUTURE END-USE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 43 APAC CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 44 CHINA CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 45 CHINA CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 46 JAPAN CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 47 JAPAN CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 48 KOREA CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 49 KOREA CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 50 INDIA CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 51 INDIA CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 52 SOUTHEAST ASIA CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 53 SOUTHEAST ASIA CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 54 MARKET SHARE BY COUNTRY
FIGURE 55 MIDDLE EAST AND AFRICA CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 56 MIDDLE EAST AND AFRICA CANNABIDIOL (CBD) CURRENT AND FUTURE ROUTE OF ADMINISTRATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 57 MIDDLE EAST AND AFRICA CANNABIDIOL (CBD) CURRENT AND FUTURE DISTRIBUTION CHANNEL ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 58 MIDDLE EAST AND AFRICA CANNABIDIOL (CBD) CURRENT AND FUTURE END-USE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 59 MIDDLE EAST AND AFRICA CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 60 SAUDI ARABIA CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 61 SAUDI ARABIA CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 62 UAE CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 63 UAE CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 64 EGYPT CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 65 EGYPT CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 66 NIGERIA CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 67 NIGERIA CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 68 SOUTH AFRICA CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 69 SOUTH AFRICA CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 70 MARKET SHARE BY COUNTRY
FIGURE 71 EUROPE CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 72 EUROPE CANNABIDIOL (CBD) CURRENT AND FUTURE ROUTE OF ADMINISTRATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 73 EUROPE CANNABIDIOL (CBD) CURRENT AND FUTURE SOURCE TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 74 EUROPE CANNABIDIOL (CBD) CURRENT AND FUTURE DISTRIBUTION CHANNEL ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 75 EUROPE CANNABIDIOL (CBD) CURRENT AND FUTURE END-USE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 76 EUROPE CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 77 GERMANY CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 78 GERMANY CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 79 FRANCE CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 80 FRANCE CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 81 UK CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 82 UK CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 83 RUSSIA CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 84 RUSSIA CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 85 ITALY CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 86 ITALY CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 87 MARKET SHARE BY COUNTRY
FIGURE 88 SOUTH AMERICA CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 89 SOUTH AMERICA CANNABIDIOL (CBD) CURRENT AND FUTURE ROUTE OF ADMINISTRATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 90 SOUTH AMERICA CANNABIDIOL (CBD) CURRENT AND FUTURE DISTRIBUTION CHANNEL ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 91 SOUTH AMERICA CANNABIDIOL (CBD) CURRENT AND FUTURE END-USE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 92 SOUTH AMERICA CANNABIDIOL (CBD) CURRENT AND FUTURE END-USE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 93 SOUTH AMERICA CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 94 BRAZIL CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 95 BRAZIL CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 96 ARGENTINA CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 97 ARGENTINA CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 98 COLUMBIA CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 99 COLUMBIA CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 100 FINANCIAL OVERVIEW:
TABLE 2 GLOBAL CANNABIDIOL (CBD) MARKET, 2020–2030, (USD MILLION)
TABLE 3 CANNABIDIOL (CBD) CURRENT AND FUTURE REGIONAL ANALYSIS, 2020–2030 (USD MILLION)
TABLE 4 GLOBAL CANNABIDIOL (CBD) HISTORICAL MARKET TYPE ANALYSIS, 2015-2019, (USD MILLION)
TABLE 5 CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 6 GLOBAL CANNABIDIOL (CBD) HISTORICAL MARKET ROUTE OF ADMINISTRATION ANALYSIS, 2015-2019, (USD MILLION)
TABLE 7 CANNABIDIOL (CBD) CURRENT AND FUTURE ROUTE OF ADMINISTRATION ANALYSIS, 2020–2030 (USD MILLION)
TABLE 8 GLOBAL CANNABIDIOL (CBD) HISTORICAL MARKET SOURCE TYPE ANALYSIS, 2015-2019, (USD MILLION)
TABLE 9 CANNABIDIOL (CBD) CURRENT AND FUTURE SOURCE TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 10 GLOBAL CANNABIDIOL (CBD) HISTORICAL MARKET DISTRIBUTION CHANNEL ANALYSIS, 2015-2019, (USD MILLION)
TABLE 11 CANNABIDIOL (CBD) CURRENT AND FUTURE DISTRIBUTION CHANNEL ANALYSIS, 2020–2030 (USD MILLION)
TABLE 12 GLOBAL CANNABIDIOL (CBD) HISTORICAL MARKET END-USE ANALYSIS, 2015-2019, (USD MILLION)
TABLE 13 CANNABIDIOL (CBD) CURRENT AND FUTURE END-USE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 14 GLOBAL CANNABIDIOL (CBD) HISTORICAL MARKET APPLICATION ANALYSIS, 2015-2019, (USD MILLION)
TABLE 15 CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030 (USD MILLION)
TABLE 16 NORTH AMERICA CANNABIDIOL (CBD) HISTORICAL MARKET ANALYSIS, 2015-2019, (USD MILLION)
TABLE 17 NORTH AMERICA CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 18 NORTH AMERICA CANNABIDIOL (CBD) CURRENT AND FUTURE ROUTE OF ADMINISTRATION ANALYSIS, 2020–2030 (USD MILLION)
TABLE 19 NORTH AMERICA CANNABIDIOL (CBD) CURRENT AND FUTURE SOURCE TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 20 NORTH AMERICA CANNABIDIOL (CBD) CURRENT AND FUTURE DISTRIBUTION CHANNEL ANALYSIS, 2020–2030 (USD MILLION)
TABLE 21 NORTH AMERICA CANNABIDIOL (CBD) CURRENT AND FUTURE END-USE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 22 NORTH AMERICA CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030 (USD MILLION)
TABLE 23 U.S. CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2015–2020
TABLE 24 U.S. CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 25 U.S. CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 26 CANADA CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 27 CANADA CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 28 MEXICO CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 29 MEXICO CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 30 APAC CANNABIDIOL (CBD) HISTORICAL MARKET ANALYSIS, 2015-2019, (USD MILLION)
TABLE 31 ASIA-PACIFIC CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 32 ASIA-PACIFIC CANNABIDIOL (CBD) CURRENT AND FUTURE ROUTE OF ADMINISTRATION ANALYSIS, 2020–2030 (USD MILLION)
TABLE 33 ASIA-PACIFIC CANNABIDIOL (CBD) CURRENT AND FUTURE SOURCE TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 34 ASIA-PACIFIC CANNABIDIOL (CBD) CURRENT AND FUTURE END-USE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 35 ASIA-PACIFIC CANNABIDIOL (CBD) CURRENT AND FUTURE END-USE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 36 ASIA-PACIFIC CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030 (USD MILLION)
TABLE 37 CHINA CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 38 CHINA CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 39 JAPAN CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 40 JAPAN CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 41 KOREA CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 42 KOREA CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 43 INDIA CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 44 INDIA CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 45 SOUTHEAST ASIA CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 46 SOUTHEAST ASIA CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 47 MIDDLE EAST AND AFRICA CANNABIDIOL (CBD) HISTORICAL MARKET ANALYSIS, 2015-2019, (USD MILLION)
TABLE 48 MIDDLE EAST AND AFRICA CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 49 MIDDLE EAST AND AFRICA CANNABIDIOL (CBD) CURRENT AND FUTURE ROUTE OF ADMINISTRATION ANALYSIS, 2020–2030 (USD MILLION)
TABLE 50 MIDDLE EAST AND AFRICA CANNABIDIOL (CBD) CURRENT AND FUTURE DISTRIBUTION CHANNEL ANALYSIS, 2020–2030 (USD MILLION)
TABLE 51 MIDDLE EAST AND AFRICA CANNABIDIOL (CBD) CURRENT AND FUTURE END-USE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 52 MIDDLE EAST AND AFRICA CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030 (USD MILLION)
TABLE 53 SAUDI ARABIA CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 54 SAUDI ARABIA CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 55 UAE CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 56 UAE CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 57 EGYPT CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 58 EGYPT CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 59 NIGERIA CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 60 NIGERIA CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 61 SOUTH AFRICA CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 62 SOUTH AFRICA CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 63 EUROPE CANNABIDIOL (CBD) HISTORICAL MARKET ANALYSIS, 2015-2019, (USD MILLION)
TABLE 64 EUROPE CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 65 EUROPE CANNABIDIOL (CBD) CURRENT AND FUTURE ROUTE OF ADMINISTRATION ANALYSIS, 2020–2030 (USD MILLION)
TABLE 66 EUROPE CANNABIDIOL (CBD) CURRENT AND FUTURE SOURCE TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 67 EUROPE CANNABIDIOL (CBD) CURRENT AND FUTURE DISTRIBUTION CHANNEL ANALYSIS, 2020–2030 (USD MILLION)
TABLE 68 EUROPE CANNABIDIOL (CBD) CURRENT AND FUTURE END-USE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 69 EUROPE CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030 (USD MILLION)
TABLE 70 GERMANY CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 71 GERMANY CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 72 FRANCE CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 73 FRANCE CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 74 UK CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 75 UK CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 76 RUSSIA CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 77 RUSSIA CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 78 ITALY CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 79 ITALY CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 80 SOUTH AMERICA CANNABIDIOL (CBD) HISTORICAL MARKET ANALYSIS, 2015-2019, (USD MILLION)
TABLE 81 SOUTH AMERICA CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 82 SOUTH AMERICA CANNABIDIOL (CBD) CURRENT AND FUTURE ROUTE OF ADMINISTRATION ANALYSIS, 2020–2030 (USD MILLION)
TABLE 83 SOUTH AMERICA CANNABIDIOL (CBD) CURRENT AND FUTURE DISTRIBUTION CHANNEL ANALYSIS, 2020–2030 (USD MILLION)
TABLE 84 SOUTH AMERICA CANNABIDIOL (CBD) CURRENT AND FUTURE END-USE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 85 SOUTH AMERICA CANNABIDIOL (CBD) CURRENT AND FUTURE END-USE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 86 SOUTH AMERICA CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030 (USD MILLION)
TABLE 87 BRAZIL CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 88 BRAZIL CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 89 ARGENTINA CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 90 ARGENTINA CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 91 COLUMBIA CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 92 COLUMBIA CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 1 GLOBAL CANNABIDIOL (CBD) MARKET, 2020–2030, (USD MILLION)
FIGURE 2 RESEARCH METHODOLOGY
FIGURE 3 GLOBAL CANNABIDIOL (CBD) CURRENT AND FUTURE MARKET, 2020–2030, (USD MILLION)
FIGURE 4 GLOBAL CANNABIDIOL (CBD) CURRENT AND FUTURE MARKET, 2020–2030, (USD MILLION)
FIGURE 5 MARKET OVERVIEW
FIGURE 6 SWOT ANALYSIS
FIGURE 7 MARKET SHARE ANALYSIS
FIGURE 8 SUPPLY CHAIN ANALYSIS
FIGURE 9 PORTER’S FIVE FORCES ANALYSIS
FIGURE 10 CANNABIDIOL (CBD) TYPE ANALYSIS
FIGURE 11 GLOBAL CANNABIDIOL (CBD) CURRENT AND FUTURE MARKET TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 12 CANNABIDIOL (CBD) ROUTE OF ADMINISTRATION ANALYSIS
FIGURE 13 GLOBAL CANNABIDIOL (CBD) CURRENT AND FUTURE MARKET ROUTE OF ADMINISTRATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 14 CANNABIDIOL (CBD) SOURCE TYPE ANALYSIS
FIGURE 15 GLOBAL CANNABIDIOL (CBD) CURRENT AND FUTURE MARKET SOURCE TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 16 CANNABIDIOL (CBD) DISTRIBUTION CHANNEL ANALYSIS
FIGURE 17 GLOBAL CANNABIDIOL (CBD) CURRENT AND FUTURE MARKET DISTRIBUTION CHANNEL ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 18 CANNABIDIOL (CBD) END-USE ANALYSIS
FIGURE 19 GLOBAL CANNABIDIOL (CBD) CURRENT AND FUTURE MARKET END-USE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 20 CANNABIDIOL (CBD) APPLICATION ANALYSIS
FIGURE 21 GLOBAL CANNABIDIOL (CBD) CURRENT AND FUTURE MARKET APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 22 GLOBAL CANNABIDIOL (CBD) CURRENT AND FUTURE MARKET VOLUME SHARE REGIONAL ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 23 MARKET OVERVIEW, REGIONAL ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 24 MARKET SHARE BY COUNTRY
FIGURE 25 NORTH AMERICA CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 26 NORTH AMERICA CANNABIDIOL (CBD) CURRENT AND FUTURE ROUTE OF ADMINISTRATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 27 NORTH AMERICA CANNABIDIOL (CBD) CURRENT AND FUTURE SOURCE TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 28 NORTH AMERICA CANNABIDIOL (CBD) CURRENT AND FUTURE DISTRIBUTION CHANNEL ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 29 NORTH AMERICA CANNABIDIOL (CBD) CURRENT AND FUTURE END-USE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 30 NORTH AMERICA CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 31 U.S. CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 32 U.S. CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 33 CANADA CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 34 CANADA CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 35 MEXICO CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 36 MEXICO CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 37 MARKET SHARE BY COUNTRY
FIGURE 38 APAC CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 39 APAC CANNABIDIOL (CBD) CURRENT AND FUTURE ROUTE OF ADMINISTRATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 40 APAC CANNABIDIOL (CBD) CURRENT AND FUTURE SOURCE TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 41 APAC CANNABIDIOL (CBD) CURRENT AND FUTURE END-USE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 42 APAC CANNABIDIOL (CBD) CURRENT AND FUTURE END-USE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 43 APAC CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 44 CHINA CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 45 CHINA CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 46 JAPAN CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 47 JAPAN CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 48 KOREA CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 49 KOREA CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 50 INDIA CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 51 INDIA CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 52 SOUTHEAST ASIA CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 53 SOUTHEAST ASIA CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 54 MARKET SHARE BY COUNTRY
FIGURE 55 MIDDLE EAST AND AFRICA CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 56 MIDDLE EAST AND AFRICA CANNABIDIOL (CBD) CURRENT AND FUTURE ROUTE OF ADMINISTRATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 57 MIDDLE EAST AND AFRICA CANNABIDIOL (CBD) CURRENT AND FUTURE DISTRIBUTION CHANNEL ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 58 MIDDLE EAST AND AFRICA CANNABIDIOL (CBD) CURRENT AND FUTURE END-USE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 59 MIDDLE EAST AND AFRICA CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 60 SAUDI ARABIA CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 61 SAUDI ARABIA CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 62 UAE CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 63 UAE CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 64 EGYPT CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 65 EGYPT CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 66 NIGERIA CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 67 NIGERIA CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 68 SOUTH AFRICA CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 69 SOUTH AFRICA CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 70 MARKET SHARE BY COUNTRY
FIGURE 71 EUROPE CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 72 EUROPE CANNABIDIOL (CBD) CURRENT AND FUTURE ROUTE OF ADMINISTRATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 73 EUROPE CANNABIDIOL (CBD) CURRENT AND FUTURE SOURCE TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 74 EUROPE CANNABIDIOL (CBD) CURRENT AND FUTURE DISTRIBUTION CHANNEL ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 75 EUROPE CANNABIDIOL (CBD) CURRENT AND FUTURE END-USE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 76 EUROPE CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 77 GERMANY CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 78 GERMANY CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 79 FRANCE CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 80 FRANCE CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 81 UK CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 82 UK CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 83 RUSSIA CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 84 RUSSIA CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 85 ITALY CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 86 ITALY CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 87 MARKET SHARE BY COUNTRY
FIGURE 88 SOUTH AMERICA CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 89 SOUTH AMERICA CANNABIDIOL (CBD) CURRENT AND FUTURE ROUTE OF ADMINISTRATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 90 SOUTH AMERICA CANNABIDIOL (CBD) CURRENT AND FUTURE DISTRIBUTION CHANNEL ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 91 SOUTH AMERICA CANNABIDIOL (CBD) CURRENT AND FUTURE END-USE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 92 SOUTH AMERICA CANNABIDIOL (CBD) CURRENT AND FUTURE END-USE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 93 SOUTH AMERICA CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 94 BRAZIL CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 95 BRAZIL CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 96 ARGENTINA CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 97 ARGENTINA CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 98 COLUMBIA CANNABIDIOL (CBD) CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 99 COLUMBIA CANNABIDIOL (CBD) CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 100 FINANCIAL OVERVIEW:
FAQ
Premium Report Details
Published On:19-Dec-21
Base Year:2024
Historical Data:2019
No of Pages:170
Buy Now
Need a Discount? Get in touch with us for special pricing
Connect with our sales team
Global Cannabidiol (CBD) Market By Source Type (He...
RD Code : CG22Subscribe Us
Sign up today for tips and latest news
and exclusive special offers.
